Best PCSK9 Inhibitor for atherosclerosis
2 PCSK9 Inhibitor drugs indicated for atherosclerosis, ranked by our independent rating. The current highest-rated is praluent. Compare them with all treatments for atherosclerosis or the full PCSK9 Inhibitor class. Not medical advice — always consult a professional.
Top pcsk9 inhibitor for atherosclerosis: 1. Praluent · 2. Repatha
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Praluent | 70/100 | Prescription | — | View → |
| 2 | Repatha | 70/100 | Prescription | — | View → |
Full ranking · 2 drugs
Frequently asked
- What is the best pcsk9 inhibitor for atherosclerosis?
- By our independent rating, praluent currently ranks highest among PCSK9 Inhibitor drugs used for atherosclerosis. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which pcsk9 inhibitor drugs treat atherosclerosis?
- pharmaranks lists 2 PCSK9 Inhibitor products indicated for atherosclerosis, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.